Post-earnings recap
Reported
Thu, Aug 8, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's strong EPS performance, significantly beating expectations, led to a notable stock increase of 9.48%. This positive reaction reflects investor confidence in the company's ongoing strategies and potential for future growth, despite the lack of revenue data and guidance updates.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.92 | N/A | +48.37% |
| Revenue | N/A | N/A | N/A |
Management expressed confidence in the company's performance, highlighting the strong EPS results. They emphasized their commitment to innovation in healthcare.
We are pleased with our strong EPS performance this quarter.
Our focus remains on delivering innovative treatments to our patients.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—